HIV drug resistance in low-income and middle-income countries
After 15 years of global scale-up of antiretroviral therapy (ART), rising prevalence of HIV drug resistance in many low-income and middle-income countries (LMICs) poses a growing threat to the HIV response, with the potential to drive an increase in mortality, HIV incidence, and costs. To achieve UN...
| Main Authors: | , , |
|---|---|
| Format: | Journal article |
| Published: |
Elsevier
2018
|